DEC 23, 2021 5:00 AM PST

Double Whammy Cytokine Hit Stops Transplant Side Effects

WRITTEN BY: Tara Fernandes

Patients who receive bone marrow or stem cell transplants are offered the gift of a new lease of life. However, sometimes the body rejects this gift with potentially catastrophic consequences. A study by researchers at UC Davis Health describes a potential antidote to this phenomenon of graft-versus-host disease (GvHD). 

Blocking the activity of two inflammatory cytokines (IL-6 and TNF) offered superior protection against GvHD compared to existing clinical approaches to resist the condition.

In GvHD, residual donor immune cells within the donated tissue recognize the host's tissue as foreign, launching a relentless attack against the recipient's organs. This immune cell activation unleashes a cytokine storm, a hyperinflammatory state which can have potentially lethal consequences in the recipient of the donor tissue. These side effects are of particular concern to cancer patients and those with certain blood disorders who routinely receive bone marrow transplant therapies. For these patients, the constant threat of GvHD significantly limits the therapeutic benefit of these transplants.

A research team led by William Murphy honed in on IL-6 and TNF as potential targets for disarming the effects of GvHD. According to the researchers, prior efforts to 'switch off' these cytokines to prevent GvHD were a flop, potentially because only one cytokine was inactivated at a time.

Murphy's team hypothesized that by simultaneously blocking both cytokines, they would keep GvHD at bay more effectively. In their study, the team found that this approach proved to shield against acute GvHD and mortality in patients who received stem cell transplants. 

The results of this study offer much-needed insights on novel approaches to treating other inflammatory diseases, such as severe COVID-19 infections.

"The increased efficacy of combined blockade suggests that this approach to treating diseases caused by inflammation may have greater benefit in other clinical settings," said Murphy.

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
JAN 30, 2022
Health & Medicine
What Happens After Omicron? Scientists' Predictions
JAN 30, 2022
What Happens After Omicron? Scientists' Predictions
Now that Omicron is running through the globe and increasing exposure to SARS-CoV-2 more than any previous variant, scie ...
APR 15, 2022
Immunology
Immune Cell Fingerprints Can Help Reveal New Autoimmune Disease Treatments
APR 15, 2022
Immune Cell Fingerprints Can Help Reveal New Autoimmune Disease Treatments
The immune system is an incredibly complex system that has to be able to rapidly spring into action, and then shut down ...
APR 21, 2022
Health & Medicine
Inhibiting a Key Signaling Pathway in Immune Cells Slows Alzheimer's Progression
APR 21, 2022
Inhibiting a Key Signaling Pathway in Immune Cells Slows Alzheimer's Progression
Weill Cornell Medicine researchers recently discovered that inhibiting a key signaling pathway in brain cells can lessen ...
APR 25, 2022
Microbiology
How a Serious Infection Can Cause Mood Disorders
APR 25, 2022
How a Serious Infection Can Cause Mood Disorders
When a pathogen invades the body, the immune system has to mount a response, which involves inflammation. But inflammati ...
APR 26, 2022
Immunology
Unraveling the Mystery of an Immune Cell Checkpoint
APR 26, 2022
Unraveling the Mystery of an Immune Cell Checkpoint
The immune system can get tired when it has to fight against a chronic infection or a disease like cancer. Exhausted T c ...
APR 28, 2022
Drug Discovery & Development
Keto Molecule Shows Promise for Treating Colorectal Cancer
APR 28, 2022
Keto Molecule Shows Promise for Treating Colorectal Cancer
A molecule produced when on low-carbohydrate ketogenic diets suppresses the growth of colorectal tumors in the lab. The ...
Loading Comments...